Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.270
+0.380 (9.77%)
At close: Nov 13, 2026, 4:00 PM EST
4.329
+0.059 (1.39%)
After-hours: Nov 13, 2026, 7:56 PM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $761.98 million as of November 13, 2026. It is the 11,609th most valuable company in the world and the 2,413th biggest in the United States. Its market cap has increased by 21.24% in one year.
Market Cap
761.98M
Enterprise Value
811.24M
1-Year Change
21.24%
Global Rank
Country Rank
#2,413 United States
Category
ChartMarket Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $761.98M, a decrease of -53.18%. That is a compound annual growth rate of -17.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 761.98M | 24.04% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 800.67M |
| Lexicon Pharmaceuticals | 796.97M |
| Ardelyx | 776.74M |
| Obsidian Therapeutics | 775.87M |
| Solid Biosciences | 763.42M |
| Annexon | 747.79M |
| Aura Biosciences | 739.97M |
| Sagimet Biosciences | 729.38M |